Funds research to improve understanding, diagnosis, and treatment of heavy menstrual bleeding in women in low-resource settings in Sub-Saharan Africa, India, and Pakistan.
Bill and Melinda Gates Foundation has archived this opportunity.
Funder: Bill and Melinda Gates Foundation
Due Dates: March 25, 2025
Funding Amounts: Up to $150,000 per project | Grant term up to 2 years | Max 15% indirect costs
Summary: Supports research to advance understanding, diagnosis, and treatment of heavy menstrual bleeding in women, with emphasis on low-resource settings in Sub-Saharan Africa, India, and Pakistan.
Key Information: Proposals must focus on original research benefiting women in designated regions; applications from women-led and LMIC-based organizations are encouraged.
This funding opportunity seeks proposals that address heavy menstrual bleeding (HMB) using its clinical definition, with an emphasis on improving understanding of biological mechanisms, disease burden, diagnostics, and access to effective treatments for women in low-resource settings. The initiative is particularly focused on Sub-Saharan Africa, India, and Pakistan, aiming to support original research and development that can lead to scalable innovations in diagnostics, standardized measurement, and patient-centered care. Proposals are expected to align with one or more of the outlined objectives, including biological research, epidemiological studies, development of diagnostics, and strategies to improve treatment access.